Harrow Health (HROW) Misses Q1 EPS by 56c
Tweet
Share
E-mailGet Alerts HROW Hot Sheet
Join SI Premium – FREE
Harrow Health (NASDAQ: HROW) reported Q1 EPS of ($0.50), $0.56 worse than the analyst estimate of $0.06. Revenue for the quarter came in at $47.8 million versus the consensus estimate of $61.13 million.
For earnings history and earnings-related data on Harrow Health (HROW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS says bull market has further to run
- H.C. Wainwright Reiterates Buy Rating on Lifeward (LFWD)
- The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
